Ibuprofen B. Braun (Ibuprofen)

Ibuprofen blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for producing prostaglandins. By lowering prostaglandin levels, it reduces pain signals, lowers elevated body temperature, and diminishes swelling and redness associated with inflammation.

The specific dose and infusion rate of Ibuprofen B. Braun are determined by the prescribing clinician based on the patient’s condition, weight, renal function, and other clinical factors. Healthcare providers follow local guidelines and product labeling to set an appropriate regimen.

Safety data for intravenous ibuprofen in pregnancy are limited. It is generally avoided in the third trimester because of potential fetal cardiovascular effects. Breastfeeding mothers should consult their physician, as ibuprofen can be excreted in milk in small amounts.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with oral NSAIDs, the intravenous form provides faster onset of analgesia and can be used when oral administration is not feasible. Its efficacy is similar to other IV NSAIDs, but the safety profile, especially gastrointestinal risk, remains comparable, requiring similar monitoring.

Ibuprofen B. Braun should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Before use, inspect the vial for particulate matter and ensure the solution is at room temperature if required for administration.

The product is given as an intravenous infusion by a qualified healthcare professional. The vial is diluted with an appropriate compatible solution and infused over the recommended time period, usually 15‑30 minutes, following the prescribing information.

Serious risks include gastrointestinal bleeding or perforation, severe allergic reactions such as anaphylaxis, acute kidney injury, and liver dysfunction. Patients with a history of ulcers, bleeding disorders, severe renal or hepatic disease, or cardiovascular disease should be monitored closely.

Ibuprofen B. Braun is contraindicated in patients with active gastrointestinal bleeding, known hypersensitivity to ibuprofen or other NSAIDs, severe renal or hepatic impairment, and in the third trimester of pregnancy unless the benefits clearly outweigh the risks.